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Post-surgical acute kidney injury
Acute kidney injury (AKI) has been proven to increase 
patient mortality in all clinical settings: general out-of-
hospital population, in-hospital admissions, adult and 
pediatric intensive care units (ICU), adult and pediatric 
cardiac surgery, and (last but not least) the relatively high 
portion formed by post-operative general surgery patients. 
In a study population of 1,166 patients without previous 
renal insuﬃ     ciency, Abelha and colleagues [1] elegantly 
showed that 7.5% met AKI criteria. Interestingly, AKI was 
diagnosed when criteria of class I (or greater) of the 
Acute Kidney Injury Network (AKIN) classiﬁ  cation were 
present. On multivariate analysis, American Society of 
Anesthesiologists (ASA) physical status, Revised Cardiac 
Risk Index (RCRI) score, high-risk surgery, and conges-
tive heart failure were identiﬁ  ed as the independent pre-
operative risk factors for AKI during the post-operative 
period. Th   e RCRI score includes the following variables: 
high-risk surgery, ischemic heart disease, congestive 
heart failure, cerebrovascular disease, and insulin-
requiring diabetes mellitus. According to these data, AKI 
patients were the most severely ill after ICU admission 
(higher Simpliﬁ  ed Acute Physiology Score II and Acute 
Physiology and Chronic Health Evalu  a  tion II), had the 
longest ICU length of stay, and were independently at 
risk for hospital mortality. In our opinion, even if the 
accompanying editorial points out that one of the most 
important limitations of this report was the exclusion of 
patients with pre-operative renal dysfunction [2] (which 
has been identiﬁ   ed as a major risk factor for peri-
operative AKI in most studies), patients with pre-
operative renal dysfunction are already those who receive 
the greater attention for prevention or treatment (or 
both) of further renal insult. So it must be remarked that 
an important message of this study is that post-operative 
AKI must be suspected in all patients with the clinical 
characteristics analyzed by Abelha and colleagues [1]. 
Th  e next step will be to analyze such a cohort for the 
eﬀ  ect of intra-operative and post-operative therapeutic 
staregies on AKI risk: the prevention from use of 
nephrotoxins (nephrotoxic antibiotics, non  steroidal anti-
inﬂ   ammatory drugs, and some forms of hydroxyethyl 
starch), the eﬀ   ort to avoid extreme intra-operative 
hypotension or anemia, and ﬁ  nally the contri  bution of 
speciﬁ  cally targeted therapies (for example, bicarbonate 
infusion, N-acetilcysteine, fenoldo  pam, poly  mixin 
hemoperfusion, and prophylactic dialysis).
Timing of renal replacement therapy
Th   e study by Abelha and colleagues [1] did not provide 
data on how many AKI patients underwent post-surgery 
renal replacement therapy (RRT). Shiao and colleagues 
[3] examined the impact of RRT timing in 98 patients 
aﬀ   ected by post-abdominal surgery AKI. Th  e patients 
were divided according to RIFLE (Risk, Injury, Failure, 
Loss of function, End-stage kidney disease) classiﬁ  cation 
into early dialysis (ED) (RIFLE-0 or Risk = 52%) and late 
dialysis (LD) (RIFLE-Injury or Failure = 48%). Fifty-seven 
patients (58.2%) died during hospitalization; LD had a 
death hazard ratio (HR) of 1.846; other factors indepen-
dently associated with risk of dying were old age (HR 
2.090), cardiac failure (HR 4.620), and pre-RRT SOFA 
(Sequential Organ Failure Assessment) score (HR 1.152). 
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© 2010 BioMed Central LtdTh  e ﬁ  ndings of this study support earlier initiation of 
acute RRT (Figure 1). Interestingly, the authors used 
RIFLE classiﬁ  cation as a prognostic tool in patients with 
post-major abdominal surgery AKI. However, deﬁ  ning 
ED and LD on the basis of RIFLE criteria may be only 
partially correct since AKI severity criteria do not 
necessarily indicate that the clinicians ‘delayed’ or 
‘anticipated’ the dialytic therapy. (A RIFLE-F stage may 
occur and require RRT soon after ICU admission. Is this 
an LD?)
As a matter of fact, timing of RRT is crucial in AKI 
critically ill patients, and there is general agreement that 
a survival beneﬁ  t is provided by early initiation of RRT. In 
clinical practice, however, to start early RRT remains 
quite a diﬃ   cult choice. Th  e  diﬀ  erentiation between ‘early’ 
and ‘late’ RRT is based on arbitrary thresholds of 
traditional parameters such as serum urea, serum 
creatinine, urine output, time from ICU admission, or 
time from AKI diagnosis [4]. Furthermore, it may happen 
that RRT is indicated at an early ICU admission stage, 
whereas late initiation of renal support is prompted in an 
advanced phase of multiple organ dysfunction syndrome; 
the diﬀ  erent clinical pictures of these two RRT prescrip-
tions may not be classiﬁ  ed simply as ‘early’ or ‘late’. Th  e 
detractors of a strategy of early initiation of RRT, ﬁ  nally, 
claim that patients who would recover renal function 
with conservative treatment alone may be subjected to 
unnecessary risks. Recently, in an interesting retro-
spective analysis of 1,847 critically ill patients with AKI 
requiring RRT, Ostermann and Chang [5] evaluated the 
relationship between biochemical, physiological, and 
comorbid factors at time of RRT and ICU mortality. 
Multivariate analysis showed that, at time of initiation of 
RRT, independent risk factors for ICU mortality were 
mechanical ventilation (odds ratio [OR] 6.03), 
neurological failure (OR 2.48), liver failure (OR 2.44), 
gastrointestinal failure (OR 2.04), pre-existing chronic 
illnesses (OR 1.74), hematological failure (OR 1.74), 
respiratory failure (OR 1.62), oligoanuria (OR 1.6), age 
(OR 1.03), serum urea (OR 1.004), and cardiovascular 
failure (OR 1.3). A higher pH at initiation of RRT was 
independently associated with a better outcome. Failure 
to correct acidosis and development of more organ 
failure within 48 hours after initiation of RRT were also 
associated with an increased risk of dying in the ICU. 
Even if these results come from a retrospective analysis 
and are, by deﬁ   nition, inconclusive, the message they 
carry seems to be that RRT should be commenced for 
AKI critically ill patients before organ failure and meta-
bolic derangements have reached the slippery threshold 
of irreversibility. An interesting and controversial part of 
the paper concerns serum creatinine and urea concen-
trations on the day of RRT start. At RRT start, survivors 
tended to have lower urea and higher creatinine levels. 
Th  is ﬁ  nding further suggests that the decision when to 
start RRT for AKI should be guided more by associated 
dysfunction of other organ systems, urine output, and 
serum pH than by absolute serum creatinine or urea 
levels (or both). Clearly, creatinine is not an ideal bio-
marker for decisions on RRT timing. Creatinine can 
result normal in the case of RRT for ﬂ  uid overload (that 
decreased creatinine levels because of hemodilution) or 
‘extrarenal’ RRT indications (a subgroup of patients with 
normal creatinine but still poor outcome). However, 
patients who received RRT before they met the creatinine 
criteria for AKIN stage III had a signiﬁ  cantly lower ICU 
mortality than patients who were started on RRT on the 
day when they met the AKIN stage III criteria (49.8% 
versus  64.6%). Th  e early start of RRT was recently 
supported by a retrospective cohort study that showed 
how initiating dialysis with a blood urea nitrogen of more 
than 100 mg/dL predicted death at 14 days (OR 3.6, 95% 
conﬁ  dence interval [CI] 1.7 to 7.6), 28 days (OR 2.6, 95% 
CI 1.2 to 5.7), and 365 days (OR 3.5, 95% CI 1.2 to 10) [6]. 
Th  ough imperfect, biomarkers for RRT initiation are the 
simplest guide that clinicians commonly follow in clinical 
practice. In this light, the new biomarkers (see below) will 
hopefully improve the performance of creatinine and urea.
Last year, in the ‘Year in review 2008: Critical Care--
nephrology’ [7], we commented on the work by Steinvall 
and colleagues [8], who analyzed AKI incidence in a 
Figure 1. Kaplan-Meier curves showing cumulative patient 
survival between early and late dialysis groups defi  ned by RIFLE 
classifi  cation. The brown solid line corresponds to the early dialysis 
group (RIFLE-0 and -I, n = 51), and the black dashed line corresponds 
to the late dialysis group (RIFLE-R and -F, n = 47). RIFLE, Risk, Injury, 
Failure, Loss of function, End-stage kidney disease; RRT, renal 
replacement therapy. Reprinted from [3].
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total body surface area (TBSA). Of these patients, 24% 
developed AKI and 3% required dialysis. Interestingly, 
Steinvall and colleagues found that approximately one 
half of patients developed AKI during the ﬁ  rst week and 
the other half developed AKI during the next week. 
Apparently, the authors’ resuscitation protocol was 
success  ful in preventing AKI but only when renal injury 
occurred in the very early phase of ICU admission. In a 
2009 study of a population of patients with TBSA burns 
of more than 40% and AKI, Chung and colleagues [9] 
aimed to determine the eﬀ   ect on mortality of early 
application of high-dose continuous venovenous hemo-
ﬁ  l  tration (CVVH) versus conservative management (ﬂ  uid 
resuscitation, minimization of nephrotoxic agents, 
utiliza  tion of intermittent hemodialysis in case of refrac-
tory acidosis, electrolyte abnormalities, sympto  matic 
ﬂ  uid overload not responsive to conservative interven-
tions, and intoxication with a dialyzable agent). Th  e 
control group was formed by a historical cohort. AKI was 
diagnosed on the basis of AKIN criteria. Th  e CVVH 
group was initiated on therapy (T0) at a median of 9 days 
after admission, whereas the control group was 
diagnosed with AKI (T0) at a median of 19 days after 
admission (P = 0.32). ‘Early AKI’, deﬁ  ned as the presence 
of AKI within 14 days from time of admission, occurred 
in 62% of patients in the CVVH group and 46% of 
patients in the control group (P = 0.24). Patients in the 
CVVH group were initially prescribed a mean hemo-
ﬁ  ltration dose of 57 ± 19 mL/kg per hour. Th  e mean 
duration of treatment was 5.6 ± 4.1 days. Th  e 28-day 
mortality was signiﬁ  cantly lower in CVVH patients than 
in controls (38% versus 71%, P = 0.011) as was the in-
hospital mortality (62% versus 86%, P = 0.04). Th  e 
authors also evaluated the eﬀ  ect of CVVH on multiple 
organ failure and showed that a signiﬁ  cant decrease in 
vasopressor requirement and a signiﬁ  cant increase in the 
ratio of partial pressure of arterial oxygen to fraction of 
inspired oxygen were seen in the CVVH group in 
comparison with controls. Th   is study strongly encourages 
the use of early CVVH even in a peculiar setting such as 
that of burned patients. A randomized trial should now 
deﬁ  nitely conﬁ  rm these results and overcome all of the 
limitations of matched controlled studies: as the authors 
acknowledge, the two populations had some small 
diﬀ  erences (in age, severity of disease, and time to AKI 
diagnosis) that might have favored the CVVH group. 
Furthermore, AKIN II patients were included in controls 
(whereas it looks like all AKI patients were treated by 
CVVH in the treatment group), and no information on 
how many controls were treated by intermittent hemo-
dialysis is provided. It looks like the historic cohort was 
undertreated, and no conclusions on RRT modality and 
dose by this study can be drawn.
DoReMi and the importance of surveying
Th  e Acute Dialysis Quality Initiative workgroup [10] 
recom  mended that researchers study technical aspects of 
RRT and worldwide utilization of diﬀ  erent techniques in 
order to clarify which renal replacement technique or 
schedule (or combination of the two) might increase 
outcomes of critically ill patients. Hence, several surveys 
on management and practice of RRT have been 
conducted in recent years [11-15]. Th  ese studies depict 
‘real world’ clinical practice patterns and their possible 
correlation with patient outcomes. A typical example of 
this kind of observational study is the Beginning and 
Ending Supportive Study (BEST). Th  is is a multicenter, 
multi  national, prospective, epidemiological study with 
the aim of elucidating diﬀ  erent aspects of AKI worldwide. 
Th   e study, conducted at 54 centers in 23 countries, lasted 
only one year and yielded information on about 1,700 
AKI patients, of whom about 70% required RRT. Several 
studies have been published after analysis of data 
provided by the survey, and six of them concerned 
technical aspects of RRT [16-21]. RRT results of the 
BEST study showed that continuous renal replacement 
therapy (CRRT) is often the preferred choice (80%) over 
intermittent renal replace  ment therapy (IRRT) (20%), 
probably because critically ill patients who receive CRRT 
are likely to be hypotensive and severely ill [16]. 
Nevertheless, it was shown among dialysis survivors that 
CRRT was an independent predictor of recovery from 
dialysis dependence at hospital discharge with respect to 
IRRT [17]. Th   e median prescribed CRRT dose during the 
survey was 20 mL/kg per hour. No technical CRRT 
feature (dose, modality, type of ﬁ  lter, or anticoagulation 
technique) seemed to correlate with mortality at 
multivariate logistic regression analysis [18]. Cost of RRT, 
according to BEST authors, is higher for continuous 
therapies with respect to intermittent dialysis. Th  e cost 
diﬀ  erence is due primarily to the utilization of dialysis 
and replacement ﬂ  uids: a dose prescription modiﬁ  cation 
from 35 to 20-25 mL/kg per hour and consequent 
decrease of ﬂ  uid requirement might allow a signiﬁ  cant 
saving of CRRT expense [19]. From the BEST database, it 
seemed that late RRT start, when considered as time 
from ICU admission, was associated with greater mor-
tality [20]. Among CRRT patients, survival was around 
50%; 60% of survivors were successfully weaned from 
renal replacement (no RRT need for at least 7 days after 
dialysis interruption); when compared with the ‘repeat-
RRT group’ (those who failed weaning), these patients 
had lower mortality, lower creatinine concentration, and 
higher urine output at the time of CRRT discontinuation 
[21].
Another important observational study, the Dose 
Response Multicentre International (DoReMi) collabora-
tive initiative, examined delivered RRT dose in patients 
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Patients were treated with either CRRT or IRRT during 
their ICU stay. Data were entered by operators into 
electronic case forms on a web server. Dose was categor-
ized as more intensive (CRRT at least 35 mL/kg per hour, 
IRRT at least six sessions per week) or less intensive 
(CRRT less than 35 mL/kg per hour, IRRT fewer than six 
sessions per week). Th  e authors analyzed 553 AKI 
patients treated with RRT: 338 received CRRT only, 87 
received IRRT only, and 128 received both forms of 
dialysis. Of note, only 22% of CRRT patients received a 
more intensive dose. As in the BEST study, no evidence 
emerged from the DoReMi study for a survival beneﬁ  t 
aﬀ  orded by higher-dose RRT: crude ICU mortality rates 
among intensive CRRT patients were 60.8% versus 52.5% 
in less intensive patients. In IRRT, this was 23.6% versus 
19.4%, respectively. On multi  variable analysis, there was 
no signiﬁ  cant association between RRT dose and ICU 
mortality. Among survivors, shorter ICU stay and 
duration of mechanical ventilation were observed in the 
more intensive RRT groups. Overall, the median 
prescribed CRRT dose was 34 mL/kg per hour, and the 
median delivered dose was about 27 mL/kg per hour. It 
might be that, in the clinical ﬁ  eld, theoretic prescription 
schedules do not ﬁ  t with practical problems encountered 
during continuous therapies; the most common causes 
for CRRT interruption were clotting of the circuit (74% of 
episodes), vascular access problem (11%), and clinical 
reasons (10%). For IRRT, the median delivered dose was 
relatively high: seven sessions per week. In regard to the 
cost issue, it should now be evaluated whether the actual 
reduction of length of stay and reduced medical resources 
utilization (that is, mechanical ventilation), together with 
the possibility that CRRT improves renal recovery among 
AKI survivors, justify the utilization of such a relatively 
expensive therapy.
Th  e results of the BEST and DoReMi studies do not 
seem to encourage or support the prescription and 
delivery of ‘intense’ RRT (that is, 35 mL/kg per hour or 
more during continuous RRT) versus less intense RRT 
(that is, 20 to 25 mL/kg per hour during continuous RRT). 
Two recent multicenter clinical trials – the random  ized 
evaluation of normal versus augmented level (RENAL) 
replacement therapy study [23] and the Veterans 
Administration/National Institutes of Health (VA/NIH) 
Acute Renal Failure Trial Network (ATN) study [24] – 
examined the impact of RRT dose on mortality in 
critically ill patients. Neither study showed a beneﬁ  t in 
outcomes by increases in intensity of RRT dose. In the 
RENAL trial, when the post hoc analysis was focused on 
the subgroup of septic patients, there was a tendency to 
lower mortality with the higher intensity approach only 
(OR 0.84, 95% CI 0.62 to 1.12). However, the deﬁ  nition of 
‘normal dose’ should be re-evaluated and compared with 
standard clinical practice [25]. It must be considered that 
both trials were rigorous clinical trials and greatly 
minimized the discrepancy between prescribed and 
delivered doses. Hence, in clinical practice, when 
20 mL/kg per hour is prescribed during continuous RRT 
(consistently with those in the RENAL and ATN studies), 
the possibility of a signiﬁ  cant reduction in dialysis dose 
delivery should be considered. As clearly shown by 
DoReMi, when clinicians prescribe RRT, they must 
consider a 25% safety margin, targeting 25 to 30 mL/kg 
per hour in order to meet the actual delivered dose of 19 
to 22 mL/kg per hour [25].
Pediatric acute kidney injury and renal 
replacement therapy
In recent years, application of AKI knowledge from the 
adult critically ill patients to the pediatric setting has 
revealed a new and interesting ﬁ   eld of research. In 
particular, cardiac surgery-associated AKI is a convenient 
clinical setting for the study of early AKI biomarkers 
since there is a temporally predictable insult to the 
kidneys and since it is possible to measure urine and 
blood levels of these biomarkers before the actual injury 
and compare them with levels at pre-speciﬁ  ed  time 
points afterwards. Th  e NGAL (Neutrophil Gelatinase-
Associated Lipocaline) Meta-analysis Investigator Group 
recently published the results of the analysis of data from 
19 studies and 8 countries; the data involved 2,538 
patients, of whom 487 (19.2%) developed AKI [26]. Th  e 
authors found that NGAL levels clearly appeared to be of 
diagnostic and prognostic value for AKI, RRT, and 
mortality, especially in cardiac surgery patients and in 
children. Levels of serum interleukin (IL)-1-beta, IL-5, 
IL-6, IL-8, IL-10, IL-17, interferon-gamma, tumor 
necrosis factor-alpha, granulocyte colony-stimulating 
factor (G-CSF), and granulocyte-macrophage colony-
stimulating factor (GM-CSF) as early biomarkers of AKI 
were also measured in a case control study of children 
undergoing cardiac surgery (18 cases and 21 controls) 
[27]. AKI was deﬁ   ned as a 50% increase in serum 
creatinine from baseline within 3 days. IL-6 levels at 2 
and 12  hours after cardiopulmonary bypass and IL-8 
levels at 2, 12, and 24  hours were associated with the 
development of AKI. In patients with AKI, IL-6 levels at 
2  hours had excellent predictive value for prolonged 
mechanical ventilation (deﬁ  ned as mechanical ventilation 
for more than 24 hours post-operatively) by receiver 
oper  ator curve (ROC) analysis, with an area under the 
ROC of 0.95. IL-8 levels at 2  hours had excellent 
predictive value for prolonged mechanical ventilation in 
all patients. Serum IL-18 levels between subjects with 
AKI and those without AKI were not diﬀ  erent. A panel of 
several AKI biomarkers, similar to those in ischemic 
heart disease diagnosis, is expected in the future in order 
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complications.
Possibly owing to the lack of speciﬁ  cally  designed 
devices, pediatric AKI requiring RRT is currently 
managed with a high occurrence of side eﬀ  ects in many 
centers. Santiago and colleagues [28] prospectively 
analyzed complications during CRRT in 174 critically ill 
children over a 13-year period. Of the studied patients, a 
relatively low percentage (7.4%) presented problems of 
venous catheterization (hematoma at the puncture site, 
hemorrhage, altered venous drainage of the lower limbs, 
and incorrect position of the jugular venous catheter 
requiring change). Hypotension at CRRT start was 
detected in one third of patients. Clinically signiﬁ  cant 
hemorrhage occurred in 10% of patients. In the ﬁ  rst 
72 hours of CRRT, the levels of sodium, chloride, and 
phosphate fell signiﬁ   cantly; total calcium increased 
signiﬁ  cantly; and the levels of potassium and magnesium 
remained unaltered; the changes in electrolyte levels 
during the course of treatment were not associated with 
mortality. Th  is study, the ﬁ   rst large analysis of the 
complication of pediatric CRRT, ﬁ  nds that complications 
in this cohort of patients are still high and may be greater 
than in adults. Th   e historical observational nature of the 
study design does not allow any deﬁ  nitive conclusion to 
be drawn and some questions are left unanswered. For 
example, are adult RRT materials safe and eﬀ  ective when 
adapted to children and newborn patients?
However, experience with pediatric CRRT is increasing 
and improved technical features of ‘pediatric-adapted’ 
dialysis machines warrant safer treatments. In particular, 
a peculiar and complex category of pediatric patient is 
the infant with multiple organ dysfunction, requiring 
both RRT and extracorporeal membrane oxygenation 
(ECMO). AKI occurs to the vast majority of ECMO 
children, who suﬀ   er from severe cardiac dysfunction 
(cardio-renal syndrome) or required aggressive mecha-
nical ventilation (lung-renal syndrome). Th  e  CRRT 
circuit is placed in parallel (blood ﬂ   ows in the same 
direction as the ECMO circuit) or in series (counter-
current to the ECMO circuit). Santiago and colleagues 
[29] described how to connect the CRRT device to the 
ECMO circuit: the inlet (arterial) line of the CRRT circuit 
was connected after the ECMO blood pump by a three-
way tap that was also used for the infusion of heparin, 
and the outlet (venous) line was connected to the circuit 
at another tap before the oxygenator. In contrast to what 
was suggested by the authors, the inlet of the CRRT 
machine may be connected after the ECMO pump and 
the ﬁ  lter outlet then returned to the ECMO circuit before 
the pump (into the reservoir, if present); the CRRT 
circuit, running countercurrent to extracorporeal 
assistance, allows the blood to be infused into the venous 
ECMO section (where the patient is drained) and then to 
be aspired from the arterial ECMO section (where blood 
returns to the patient) [30]. Th  is second set-up might 
reduce blood ﬂ   ow resistance and turbulence after the 
centrifugal pump and improve reservoir drainage when a 
roller pump is present. Th   e blood recirculation induced 
by these circuit set-ups is negligible, considering that the 
ratio of CRRT to ECMO blood ﬂ  ow is never greater than 
0.1. Shaheen and colleagues [31] recently reported their 
experience with two diﬀ  erent subgroups of children: one 
that required hemoﬁ  ltration alone and one that required 
hemoﬁ  ltration and ECMO. Not surprisingly, the authors 
identiﬁ   ed a higher mortality rate in those patients 
requiring CVVH and ECMO compared with those 
patients requiring hemoﬁ   ltration alone. Th  e authors 
promoted the concept that certain therapies should be 
reserved for experienced teams. Performing CVVH in a 
heterogeneous population with large ranges of age and 
weight poses signiﬁ  cant clinical and technical challenges. 
Th  e low frequency of CVVH use, as well as the use of 
other extracorporeal therapies, also raises problems with 
maintaining nursing skills. Objective clinical and 
biochemical markers for commencing CVVH alone or in 
combination with ECMO remain to be deﬁ  ned. Several 
studies, however, already showed safety and feasibility of 
this connection in the pediatric setting [32], and even if 
concerns about such diﬃ   cult interaction have been raised 
(that is, ﬂ  uid balance accuracy [33]), the application of 
CRRT to all ECMO patients is claimed by some authors 
[34]. In 15 patients matched with 46 historical controls, it 
has been shown that adding continuous hemoﬁ  ltration to 
the ECMO circuit in newborns improves outcome by 
signiﬁ  cantly reducing time on extracorporeal assistance 
and on mechanical ventilation. Such a strategy might 
improve ﬂ   uid balance management and capillary leak 
syndrome. Furthermore, according to these authors, 
fewer blood transfusions are needed and overall costs per 
ECMO run are lower.
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